Vir Biotechnology (VIR) Asset Utilization Ratio (2019 - 2026)

Vir Biotechnology has reported Asset Utilization Ratio for 8 years, with the latest figure at 0.06 in Q1 2026.

• Quarterly Asset Utilization Ratio rose 319.29% year-over-year to 0.06 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.06 (up 319.29% YoY) and the FY2025 annual result came in at 0.06, up 27.63% from the prior year.
• Asset Utilization Ratio retreated to 0.06 in Q1 2026 per VIR's latest filing, from 0.07 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 0.96 in Q1 2022 and troughed at 0.02 in Q2 2025.
• A 5-year average of 0.24 and a median of 0.06 in 2023 frame the typical range for Asset Utilization Ratio.
• The sharpest annual moves came in 2022 and 2023: Asset Utilization Ratio surged 1909.12% in 2022, then sank 94.02% in 2023.
• Over 5 years, Asset Utilization Ratio stood at 0.62 in 2022, then tumbled by 92.96% to 0.04 in 2023, then rose by 10.39% to 0.05 in 2024, then surged by 41.26% to 0.07 in 2025, then retreated by 4.67% to 0.06 in 2026.
• According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.06, 0.07, and 0.02 for Q1 2026, Q4 2025, and Q3 2025 respectively.